# DeliNova Therapeutics funding rounds and investors

As of 27 Oct 2026, DeliNova Therapeutics has raised $15.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: approximately RMB 100 million pre-A round, announced 26 Oct 2026.

Develops experimental in vivo CAR-T therapies

Headquarters: Shanghai, China  
Page: https://fireround.dev/companies/delinova-therapeutics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-26 | Pre-A | approximately RMB 100 million | not stated | GAGE Capital, Hanyuan Asset, Hongfeng Investment, Legend Holdings, Proxima Investment | [techstartups.com](https://techstartups.com/2026/10/26/startup-funding-news-today-october-26-2026-ailytics-approaching-ai-casbot-volare-more), [vcbeathealth.com](https://www.vcbeathealth.com/article/63849) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.